Nintedanib Esylate

Overview

Nintedanib Esylate is a tyrosine kinase inhibitor used in the treatment of idiopathic pulmonary fibrosis and certain types of non-small cell lung cancer. It inhibits multiple receptor pathways, leading to reduced tumor angiogenesis and fibrosis.

API suppliers (2)

Suppliers of Nintedanib Esylate backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• VERANOVA LP1 active DMF
• Sun Pharmaceutical Industries LimitedIndia1 active DMF

Therapeutic areas